Crystalvue Medical Corporation (6527.TWO)

TWD 85.3

(-0.7%)

EBITDA Summary of Crystalvue Medical Corporation

  • Crystalvue Medical Corporation's latest annual EBITDA in 2023 was 149.73 Million TWD , down -11.71% from previous year.
  • Crystalvue Medical Corporation's latest quarterly EBITDA in 2024 Q2 was 43.3 Million TWD , down -9.12% from previous quarter.
  • Crystalvue Medical Corporation reported an annual EBITDA of 169.58 Million TWD in 2022, up 12.14% from previous year.
  • Crystalvue Medical Corporation reported an annual EBITDA of 151.22 Million TWD in 2021, up 68.57% from previous year.
  • Crystalvue Medical Corporation reported a quarterly EBITDA of 43.3 Million TWD for 2024 Q2, down -9.12% from previous quarter.
  • Crystalvue Medical Corporation reported a quarterly EBITDA of 44.32 Million TWD for 2024 Q3, up 2.36% from previous quarter.

Annual EBITDA Chart of Crystalvue Medical Corporation (2023 - 2019)

Historical Annual EBITDA of Crystalvue Medical Corporation (2023 - 2019)

Year EBITDA EBITDA Growth
2023 149.73 Million TWD -11.71%
2022 169.58 Million TWD 12.14%
2021 151.22 Million TWD 68.57%
2020 89.73 Million TWD -32.72%
2019 133.34 Million TWD 0.0%

Peer EBITDA Comparison of Crystalvue Medical Corporation

Name EBITDA EBITDA Difference
St.Shine Optical Co.,Ltd. 1.01 Billion TWD 85.19%
Bioteque Corporation 736.13 Million TWD 79.66%
Chi Sheng Pharma & Biotech Co., Ltd 117.55 Million TWD -27.374%
Sunder Biomedical Tech. Co., Ltd. 76.61 Million TWD -95.438%
BenQ Medical Technology Corporation 532.15 Million TWD 71.863%
Pacific Hospital Supply Co., Ltd 673.8 Million TWD 77.778%
Unicon Optical Co., Ltd. 377.24 Million TWD 60.31%
Formosa Optical Technology Co.,Ltd. 1.04 Billion TWD 85.678%
Medeon Biodesign, Inc. -1.14 Billion TWD 113.112%
Concord Medical Co., Ltd. 137.47 Million TWD -8.916%
Perfect Medical Industry Co., Ltd. 115.48 Million TWD -29.66%
ICARES Medicus, Inc. 165.54 Million TWD 9.551%
Lagis Enterprise Co., Ltd. 112.36 Million TWD -33.255%
Amed Co., Ltd. 157.32 Million TWD 4.828%